Showing results (21-30 of 27) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
The American Journal of Clinical Nutrition|January 9, 2007
A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac diseaseCarlo Catassi, Elisabetta Fabiani, Giuseppe Iacono, et al.Biologics : Targets & Therapy|January 19, 2019
Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn's disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experiencePatrizia Alvisi, Serena Arrigo, Salvatore Cucchiara, et al.Applied Immunohistochemistry & Molecular Morphology : AIMM|March 29, 2011
Changes in immunohistochemical levels and subcellular localization after therapy and correlation and colocalization with CD68 suggest a pathogenetic role of Hsp60 in ulcerative colitisGiovanni Tomasello, Vito Rodolico, Monica Zerilli, et al.Biology|May 24, 2024
Nanovesicular Mediation of the Gut-Brain Axis by Probiotics: Insights into Irritable Bowel SyndromeRadha Santonocito, Letizia Paladino, Alessandra Maria Vitale, et al.Nutrients|January 11, 2025
Celiac Disease and Liver Damage: The Gut-Liver Axis Strikes Back (Again)? A Retrospective Analysis in the Light of a Literature ReviewAurelio Seidita, Federica Latteri, Mirco Pistone, et al.Paediatric Drugs|December 16, 2021
Real-Life Use of Biosimilars in Pediatric Inflammatory Bowel Disease: A Nation-Wide Web Survey on Behalf of the SIGENP IBD Working GroupValeria Dipasquale, Massimo Martinelli, Marina Aloi, et al.Journal of Crohn'S & Colitis|October 9, 2018
A Propensity Score-matched Comparison of Infliximab and Adalimumab in Tumour Necrosis Factor-α Inhibitor-naïve and Non-naïve Patients With Crohn's Disease: Real-Life Data From the Sicilian Network for Inflammatory Bowel DiseaseFabio Salvatore Macaluso, Walter Fries, Antonio Carlo Privitera, et al.Pageof 3